Christine S. Kim

Full contact info

About Christine

Christine practices corporate and securities law, with an emphasis on public company representation and capital markets transactions. She represents public and private companies in a wide range of corporate and securities matters – including public offerings, Securities and Exchange Commission (SEC) reporting and compliance, private financings, and corporate governance. She also is co-chair of Cooley’s Asian Pacific Islander Attorney Affinity Group.

Christine’s representative transactions include advising:

  • Structure Therapeutics in its $185 million initial public offering (IPO) and $300 million private investment in public equity (PIPE) transaction
  • Genelux Corporation in its $17 million IPO
  • Drata in its $200 million Series C financing
  • Design Therapeutics in its $125 million Series B financing and $240 million IPO
  • Immunome in its $230 million follow-on offering


University of California at Los Angeles School of Law
JD, 2018

Pepperdine University
BA, 2015, Political Science and Sociology, honors in Political Science